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Objective: Percutaneous access during endovascular aneurysm repair has been difficult owing to the large size of the
delivery catheters. This study reports a single-center experience of totally percutaneous access during endovascular
abdominal and thoracic aortic repairs using the Perclose Proglide device (Abbott Vascular, Redwood City, Calif).
Methods: Between December 2004 and August 2006, 262 endovascular aortic aneurysm repairs were performed.
Percutaneous access was used for the introduction of 12F to 24F sheaths (4.4-mm to 8.6-mm outer diameter). The
technique involved deployment of two Proglide devices before insertion of the sheath (“Preclose” technique) with the
sutures left extracorporeally for closure after conclusion of the procedure. A prospectively maintained endovascular
database and medical records were retrospectively reviewed. Rates of technical success, failure modes, and the overall
duration of the endovascular repair compared with a similar cohort using open femoral exposures were examined.
Results: A total of 559 Proglide devices were used to close 279 femoral arteries, and 175 (63%) required the insertion of
18F to 24F sheaths. There were 16 failures, mainly due to obesity, device malfunction, severe calcific disease, and faulty
arterial punctures, for a technical success rate of 94.3%. The success rates for 12F to 16F size sheaths were significantly
higher than for the larger 18F to 24F sheaths (99.0% vs 91.4%, P< .01). For both endovascular abdominal (EVAR) and
thoracic (TEVAR) aortic repairs, the Preclose technique resulted in shorter overall procedure times compared with a
similar cohort in which open femoral exposures were used (EVAR, 115 vs 128 min, P < .001; TEVAR, 80 vs 112, P 
.019). Despite this reduction of procedure time, the savings on the cost of operating room time was negated by the cost
of the Proglide devices ($295 per device).
Conclusions: Percutaneous access for endovascular aortic repair is safe and feasible using the Proglide device. Although the
success rates are higher for smaller size sheaths, successful closures may be obtained for up to 24F sheaths. Percutaneous
access may result in shorter overall procedure times and potentially lower operating room costs, but this appears to be
offset by the cost of the closure devices. ( J Vasc Surg 2007;45:1095-1101.)Suture-mediated closure devices may be used to obtain
early hemostasis after percutaneous arterial access without
the need for manual compression and prolonged bedrest;
however, these devices have been limited to closure of small
diameter (10F) sheaths. Endovascular abdominal
(EVAR) and thoracic (TEVAR) aortic repairs typically in-
volve sheaths and delivery catheters with 18F to 25F pro-
files (6.7 to 8.9 mm outer diameter), which are beyond the
treatable range of arteriotomies of these closure devices.
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doi:10.1016/j.jvs.2007.01.050A technique of closing arteriotomies after percutaneous
access with up to 22F sheaths has been previously described
(“Preclose” technique) using the 10F Perclose Prostar XL
(Abbott Vascular, Redwood City, Calif) off-label by de-
ploying the device before insertion of the large sheath with
the sutures left out and tied at the end of the procedure.1
Technical success was 62% to 100% in the reported series
and was partly dependent on the sheath size used.1-7 In this
study, we report a large single institutional experience with
the method and outcomes of a variation of the Preclose
technique using the 6F Perclose Proglide (Abbott Vascu-
lar) device during endovascular aortic repairs.
METHODS
All patients who underwent EVAR and TEVAR at a
single tertiary care university medical center between Oc-
tober 2003 and August 2006 were identified by a retro-
spective review of a prospectively maintained endovascular
database and medical records. A cohort of 183 consecutive
patients who underwent percutaneous femoral access re-
quiring 12F to 24F (4.4-mm to 8.6-mm outer diameter)
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device were compared with a consecutive, contemporane-
ous series of 154 patients who underwent open surgical
exposure of their femoral arteries. The decision on which
method of femoral access was used depended on anatomic
factors and surgeon preference. Two of the four operators
who contributed to the current case series preferentially
used surgical exposure for their femoral access.
The distribution of devices is given in Table I. Al-
though there were some differences in the frequency of
devices between the two groups, the proportion of EVAR
and TEVAR cases (P  .13) was similar. A variety of
anesthetic techniques were used, depending on patient
comorbidities and operator preferences, but the distribu-
tion of techniques for the Preclose and surgical groups,
respectively, were similar: general, 49% vs 55%; regional,
45% vs 44%; and local, 5% vs 1% (P .10). The two cohorts
were analyzed on a per groin basis. The Preclose group was
further divided into a group consisting of smaller 12F to
16F sheaths and a group consisting of larger 18F to 24F
sheaths, which are the typical profiles required for thoracic
and abdominal endograft iliac limbs and main devices,
respectively.
Perioperative outcomes, procedure times, and operat-
ing room usage costs (exclusive of any devices or dispos-
ables) were examined. Procedure time was defined as the
period of time from either incision (surgical exposure) or
skin puncture (Preclose technique) to final dressing appli-
cation. At our institution, the usage cost of the operating
room is (US) $3935 for the first 60 minutes (not prorated
for shorter periods) and then $50/min thereafter.
Technical success (in-hospital or 30-day) of the Pre-
close technique was defined as closure of the arteriotomy
without the need for any access site–related adjunctive
surgical or endovascular procedures stemming from hem-
orrhagic, infectious, or ischemic complications. Similarly,
technical success for surgical exposures was defined as pri-
Table I. Distribution of abdominal and thoracic
endovascular devices between Preclose and surgical
exposure groups
Device Preclose Surgical P
EVAR
Zenith* 81 63 .58
Excluder† 28 42 .01
AneuRx‡ 2 3 .38
Other 3 0 .25
TEVAR
TAG† 67 27 .0001
Talent‡ 1 11 .002
TX2* 1 8 .01
Total cases 183 154
EVAR, Endovascular repair; TEVAR, thoracic endovascular repair.
*Cook, Bloomington, Ind.
†W. L. Gore & Associates, Flagstaff, Ariz.
‡Medtronic, Minneapolis, Minn.mary suture repair of the arteriotomy without the need foradditional local reconstruction such as endarterectomy,
patch angioplasty, or interposition grafting.
For both groups, access site–related complications such
as seromas, infections, wound dehiscence requiring dress-
ing changes, hematomas with or without transfusions, and
prolongation of hospitalization were counted as failures of
the therapy regardless of whether they required additional
postoperative surgical or endovascular intervention. Mod-
erate or large (2 cm) asymptomatic or subclinical hema-
tomas or seromas and arteriovenous fistulas were included
as complications.
The first postoperative computed tomography (CT)
scan was typically obtained at the 1-month follow-up visit.
This and all subsequent CT scans always included the
femoral vessels.
Statistical analyses were performed using the Student t
test for continuous variables and the Fisher exact test for
categoric variables. All aggregate values are given as mean
 standard deviation. Significance was achieved at P .05.
This study was approved by the Institutional Review Board.
Perclose Proglide. This is a 6F suture-mediated clo-
sure device that is inserted over a 0.035-inch guidewire and
designed to close arteriotomies after 5F to 7F sheaths. A
single 3-0 polypropylene suture is deployed with a full-
thickness vertically oriented bite of the artery using a pair of
nitinol needles. The two strands of a preformed slipknot are
color-coded to indicate the tying strand and the locking
strand. The arteriotomy is closed by pulling on the tying
strand, pushing down the preformed slipknot using the
accompanying knot pusher, and locking the knot by re-
tracting on the locking strand. The guidewire is removed
during the deployment of the sutures but is replaced before
removal of the device to maintain access to the artery. The
list price for each device is (US) $295.
Surgical exposure technique. The common femoral
artery was exposed using a 4-cm to 6-cm transverse oblique
incision made just below the inguinal ligament. The inci-
sion was continued down through the subcutaneous tissues
to the level of the femoral sheath, where the dissection was
oriented longitudinally directly anterior to the femoral
artery. Approximately 2 to 3 cm of the artery was circum-
ferentially exposed. The artery was punctured using an
18-gauge needle through a separate stab incision placed 3
to 4 cm inferior to the incision to allow a shallower angle of
entry into the artery and the incision to collapse during the
procedure. The arteriotomy was closed with 5-0 polypro-
pylene suture using standard techniques. Adjunctive end-
arterectomies, with or without patch angioplasties, were
performed as necessary.
In cases of proximal iliac occlusive disease or severe
arterial scarring from prior closure devices or multiple
femoral catheterizations, we preferentially use serial dilators
(Coons dilator, Cook, Inc, Bloomington, Ind) to “Dotter”
the stenoses or enlarge the femoral arteriotomy. We also
liberally use these dilators to gauge the size and quality of
the access vessel before attempting insertion with the en-
dograft delivery catheter.
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accessed percutaneously using a micropuncture kit consist-
ing of 21-gauge needle with a 0.018-inch guidewire and 3F
introducer (Galt Medical Corp, Garland, Tex). Care was
taken to puncture the common femoral artery along its
anterior aspect at least 1 cm proximal to the origin of the
profunda femoris artery. This was always confirmed with a
small manual injection of contrast using an ipsilateral
oblique projection of the image intensifier.
A 0.035-inch guidewire was inserted into the aorta and
the puncture site dilated with a 7F sheath. A Proglide
device was advanced over the guidewire, rotated medially
approximately 30°, and deployed, but the strands were left
out extracorporeally and tagged with a small clamp. Guide-
wire access was maintained, and a second Proglide device
was inserted, rotated laterally 30°, and deployed. After this
device was removed, hemostasis was maintained by rein-
serting the 7F sheath. This procedure was repeated for the
contralateral side for EVAR (unilateral for TEVAR). The
access site was serially dilated (Coons dilator), over a stiff
guidewire and after systemic heparinization, to match the
outer diameter of the device introducer sheath or delivery
catheter to facilitate its entry.
Most introducer sheaths and delivery catheters have a
step-off or a “lip” at the interface between the dilator and
the outer sheath. We were concerned that this step-off
could catch on the subcutaneous tissue or, even worse, on
the Perclose suture. The leading edge of most sheaths is
purposely tapered to minimize this step-off. This edge
could get frayed during its passage through the subcutane-
ous tissue and cause further arterial injury. We believed that
predilating the tract could potentially minimize this risk.
The cost of the dilator set is (US) $170.44.
After conclusion of the endovascular repair, the in-
troducer sheath was slowly removed while manual com-
pression was applied to the groin. Stiff 0.035-inch guide-
wire access was maintained, and the preformed knots of
the two sutures were cinched down over the guidewire.
Manual pressure was released from the groin. After ver-
ification of adequate hemostasis, the guidewire was re-
moved, and manual pressure was reapplied to the groin.
A third Proglide device was deployed before removal of
the guidewire in select cases if there was persistent
pulsatile bleeding after the second suture was cinched
down.
Surgical conversion was indicated if this third device
failed to resolve the bleeding. In these cases, a 12F dilator
was reinserted over the guidewire to plug the arteriotomy,
and the artery was repaired surgically. It was critical to the
safety of this technique that guidewire access be maintained
until adequacy of hemostasis could be verified. Distal per-
fusion was confirmed with continuous-wave Doppler im-
aging, and anticoagulation was fully reversed to restore the
activated clotting time to150 seconds. Compression was
maintained for 5 to 10 minutes and the patient kept at
bedrest for 4 to 6 hours.RESULTS
Preclose technique group. Between December 2004
and August 2006, 262 endovascular aortoiliac repairs were
performed (137 EVAR, 118 TEVAR, 7 iliac). Of the 381
femoral arteries accessed for insertion of 12F to 24F
sheaths, 279 (73.2%) were managed with 559 Proglide
devices using the Preclose technique in 183 patients (105
EVAR, 71 TEVAR, 7 iliac). Four femoral arteries (1.4%)
required only one device, 270 (96.8%) were closed with
two devices, and five arteries (1.8%) required a third device.
The four femoral arteries that used only one device all
involved 12F sheaths and occurred early in our experience.
Although all four cases were successful, two devices were
routinely used for all subsequent cases. The distribution of
sheath sizes is given in Fig 1. Large size sheaths (18F)
comprised63% (175/279) of the sheaths in the Preclose
cohort.
The overall technical success rate of the Preclose tech-
nique was 94.3% (263/279 femoral arteries). There were
16 complications (ie, failures) requiring open repair of 13
femoral arteries and emergency placement of a covered
stent in two arteries for severe retroperitoneal hemorrhage.
One case of necrotizing arteritis with a mycotic pseudoan-
eurysm presented on postoperative day 27 that required a
common femoral artery replacement with autogenous fem-
oral vein (Table II). Between the subsets of smaller and
larger size sheaths, the technique was significantly more
successful in the former group at 99% (103/104) vs 91.4%
(160/175, P  .01; Fig 2). There were no other hemato-
mas, pseudoaneurysms, or other access-related complica-
tions that required additional surgical or endovascular in-
terventions. All cause mortality was 2.2% (4/183), but
access-related mortality was 0%.
Surgical exposure group. Between October 2003
and August 2006, 154 consecutive endovascular aortic
repairs (108 EVAR and 46 TEVAR) that only involved
Fig 1. Distribution of sheath sizes in the Preclose (striped) and
surgical (solid) cohort. There were significantly higher proportions
of 16F sheaths in the Preclose group (*P .03) and 18F sheaths in
the surgical group (#P  .0001).femoral introduction of the devices were identified (total of
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involved alternative access, such as iliac or aortic sites, were
excluded. The distribution of sheath sizes among the 258
surgical femoral exposures was largely similar to the Pre-
close group except where noted (Fig 1). A total of 16
intraoperative and early postoperative complications re-
sulted in a technical success rate of 93.8% (242/258; P 
Table II. Detail of reasons for Preclose failure*
No.
Sheath
(F) Reason(s) for failure Treatment
1 24 Coagulopathy, persistent bleeding Open repair
2 18 Coagulopathy, persistent bleeding Open repair
3† 24 High (suprainguinal) puncture
Retroperitoneal hemorrhage Endo
4† 20 High (suprainguinal) puncture Endo
Retroperitoneal hemorrhage
Tortuous iliac artery
5 22 Focal dissection, limb ischemia Open repair
6 18 Obesity, subcutaneous deployment Open repair
7 16 Sutures pulled through artery Open repair
8 20 Focal dissection, limb ischemia Open repair
9 18 Low SFA deployment Open repair
Focal dissection
Limb ischemia
10 20 Severely scarred groin Open repair
11 24 Persistent bleeding Open repair
12 20 Suture pulled through artery Open repair
13 20 Suture pulled through artery Open repair
14 18 Suture pulled through artery Open repair
15 20 Suture pulled through artery Open repair
16 20 Mycotic pseudoaneurysm (POD 27) Open repair
Endo, Endovascular repair; SFA, superficial femoral artery; POD, postoper-
ative day.
*15 of the 16 failures occurred intraoperatively; only one patient (patient
16) required postoperative surgical repair, which was for a necrotizing
arteritis using autogenous conduit.
†A Viabahn (W. L. Gore & Associates, Flagstaff, Ariz) covered stent was
used for the repair.
Fig 2. Technical success rate by sheath size for the Preclose
technique..86, compared with Preclose technique). The 16 complica-tions consisted of 10 endarterectomies with patch angio-
plasties, 3 wound infections, 2 infected seromas requiring
incision and drainage, and 1 severe arteritis that required
débridement and replacement of the common femoral
artery with an autogenous femoral vein. All cause mortality
was 1.3% (2/154; P  .69, compared with Preclose tech-
nique) with 0% access-related mortality (Table III).
Procedure durations and operating room costs.
The mean duration of the procedure was compared be-
tween a consecutive series subset of the 149 patients in the
Preclose cohort that only involved percutaneous transfemo-
ral accesses (101 EVAR, 48 TEVAR) and the surgical
exposure group. For both types of procedure, the Preclose
technique resulted in a shorter mean procedure time than
surgical exposure (Table III). This translated into a lower
operating room usage cost. However, when the weighted
average cost of the closure device per groin ($591.06) was
included, the EVAR Preclose group was more expensive
than the surgical group, and the TEVAR Preclose group
maintained a slight cost advantage.
DISCUSSION
Percutaneous access during endovascular aortic repairs
has been difficult because of the large sizes of the delivery
systems. Avoidance of surgical femoral exposure may result
in shorter procedure time, fewer wound complications, and
increased patient comfort. The practical size limit of achiev-
ing hemostasis with manual compression alone is likely 12F
(sheath), although this has never been formally studied.
Among the various percutaneous arterial closure devices,
suture-mediated devices offer the purported advantages of
a permanent suture, the least amount of intravascular and
extravascular foreign material, and similarity with conven-
tional arterial repair.
In this study, we retrospectively examined the safety
and effectiveness of percutaneous closure of femoral arter-
ies after introduction of 12F to 24F sheaths using a suture-
mediated closure device. Although the successful closure
was slightly higher for 12F to 16F sheaths, the overall rate
of technical success was 94% in a consecutive series of
nearly 300 femoral arteries. Furthermore, almost all of the
complications occurred intraoperatively and were amenable
to treatment with surgical or endovascular methods, and
there was no access-related mortality.
Several authors have previously described the Preclose
technique of percutaneous femoral closure after large
sheath access.1-7 The entire reported experience, however,
has solely involved the use of the Perclose Prostar XL
device, the technical success rates have varied widely from
62% to 100%, and similar with the current study, closures of
smaller sheaths (18F) were better than larger ones (Table
IV). In contrast with the Proglide device used in the current
study, the Prostar XL:
1. has a larger profile (10F vs 6F) that requires more
extensive subcutaneous dissection for the sutures to
accommodate the 24F collar of the device and allow the
sutures to seat properly,
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relies on accurate placement of four needles for its two
sutures vs two needles with one suture,
3. uses a braided suture (vs monofilament) with increased
potential for infections and occasional failure of the slip
knots to slide down, and
4. relies on the operator to tie the proper slipknot after
removal of the large sheaths.
Admittedly, all of these relative disadvantages can be
overcome with proper technique and sufficient experience.
The only advantage that the Prostar XL technique offers
over the Proglide is that it typically requires only one device
per femoral artery because there are already two sutures
oriented in a cross-pattern and, therefore, there is a cost
benefit ($425 per device vs $590 for 2 Proglide devices, a
difference of $165).
Although review of the time points at which each of the
complications occurred did not demonstrate a clear learn-
ing curve, the cases serve to illustrate a few key points about
their management and the apparent risk factors for techni-
cal failure. Proper initial femoral puncture (ie, anterior
Table III. Comparison between subsets of Preclose and s
Technique
EVAR
Preclose Surgical
Patients (n) 101 108
Femoral arteries (n) 173 212
Age (years) 71  8 72  9
Male:Female 91:10 98:10
EIA (mm) 8.8  1.3 8.8  1.5
Complication (%)* 11 (11) 10 (9.2)
Mortality (%)† 1 (1.0) 2 (1.9)
Procedure time‡ 115  45 128  31
OR cost $6697  $2240 $7351  $1557
OR cost  Proglide§ $7881 $7351
EVAR, Endovascular repair; TEVAR, thoracic endovascular repair; EIA, ex
*Access-related failure/complication only.
†All-cause mortality.
‡Duration in minutes of endovascular procedure.
§Mean only.
Table IV. Review of previously reported experience on
percutaneous closures of access sites after endovascular
repair (all using the Prostar XL)
First author Date Vessels (N) Sheath (F) Success rate
Haas1 1999 13 16, 22 100%
Traul2 2000 29 16, 22, 24 Overall, 62%
16F, 71%
22F, 75%
24F, 25%
Teh4 2001 82 16-20, 22 85%
Howell3 2001 148 16 94%
Kennedy6 2003 15 16 80%
Torsello7 2003 27 14-24 87%
Morasch5 2004 94 12, 18 81%aspect of the mid-common femoral artery) is critical. In thecase of a suprainguinal puncture of the external iliac artery,
the inguinal ligament can impede complete laying-down of
the slipknot and the access site is too high for manual
compression, leading to uncontrolled hemorrhage. This
occurred in two cases. In both, this was not immediately
recognized from the small amount of bleeding at the punc-
ture site and the guidewire was removed. In both of these
instances, the proximal superficial femoral artery was rap-
idly exposed through a medial longitudinal incision, guide-
wire access was re-established, and a short covered Viabahn
stent (W. L. Gore & Associates, Flagstaff, Ariz) was de-
ployed.
These cases notwithstanding, the ability to maintain
guidewire access from the beginning to the end of the
closure allows management of most hemorrhagic compli-
cations by reinsertion of a sheath or large dilator, restora-
tion of hemostasis, and unhurried surgical repair of the
arteriotomy. In contrast with a suprainguinal puncture, a
low femoral puncture (ie, superficial femoral artery) can
result in a flow-limiting dissection with limb ischemia due
to the small size of the entry vessel.
Any anatomic configuration that necessitates a signifi-
cant amount of pushing or torquing of the sheath or
delivery catheter can increase the risk of failure of the
Preclose technique. This occurs most commonly in patients
with small or diseased iliac arteries, or severe iliac tortuosity,
or both. The increased pressure and torque applied to the
sheath may extend the size of the arteriotomy made by the
sheath profile alone. Furthermore, it may also cause the
Proglide sutures to actually pull out of the vessel altogether
or reduce their purchase such that they are insufficient to
reappose the arteriotomy.
We believe that the ability to completely reverse the
anticoagulation is important to the technique. Similar to
open surgery, formation of clot is essential for hemostasis.
Two patients were coagulopathic despite infusions of
plasma, platelets, and protamine. There was persistent
al exposure groups
TEVAR
P Preclose Surgical P
48 46
48 46
.84 68  15 72  11 .11
1.00 39:9 35:11 .62
.96 9.4  1.4 9.5  1.7 .59
.82 5 (10) 6 (13) .76
1.00 3 0 .24
.001 80  34 112  48 .019
.01 $5087  $1533 $6556  $2399 .001
$5679 $6556
iliac artery diameter; OR, operating room.urgic
ternalbleeding and the artery repaired surgically. Direct examina-
tions
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correctly and sutures securely tied, but pulsatile bleeding
between the sutures and needle holes. We now consider
coagulopathy a contraindication to this technique.
Severe calcifications, groin scarring, and obesity can
also lead to technical complications (Fig 3). Groin scarring
from prior catheterizations and, ironically, from previously
placed percutaneous closure devices or surgery can cause
misdeployment of the Proglide sutures due to the inability
of the needles to penetrate through the arterial wall or the
overlying scar tissue. This increased resistance can lead to
the separation of the suture from the back end of the
needle. Although obesity as a single measure is not neces-
sarily a risk factor, as it relates to the depth of the subcuta-
neous tissue at the groin, it can negatively affect the ability
to properly insert the Proglide device into the artery.
To summarize, we would consider contraindications to
the procedure to be:
1. obesity, but of more importance a thick pannus in the
groin vs generalized overweight state or truncal obesity
not involving the groins,
2. severely scarred groin from multiple prior catheteriza-
tions or surgical procedures because the Proglide nee-
dles may not penetrate through the scar,
3. high (suprainguinal ligament) femoral bifurcation be-
cause hemorrhage cannot be easily controlled with man-
ual compression,
4. need for frequent introducer sheath removals and inser-
tions,
5. proximal iliac occlusive disease,
6. small iliofemoral arteries relative to the profile of the
device being inserted, and
7. anterior or near circumferential calcific disease.
It was encouraging that there were so few infectious
complications in the Preclose group. We attribute this to
Fig 3. Computed tomography images illustrate anatom
obesity with thick pannus. B, Severe iliofemoral calcificathe sterile technique and environment of the operatingroom. Indeed, the only such complication in our series
involved a polytrauma victim with a thoracic aortic tran-
section that was repaired with a stent graft. The emer-
gency conditions and a potentially unrecognized break
in sterile technique may have contributed to the Perclose
infection and resultant mycotic femoral pseudoaneu-
rysm. As with any procedure involving implantable en-
dovascular devices, the highest level of aseptic technique
is critical to avoid limb and life-threatening infectious
complications.
The main limitation of this study is its retrospective
design and its inherent selection bias. The criteria for
deciding who undergoes surgical exposures or the Pre-
close technique were not standardized. Arguably, the
surgical group may have been anatomically disadvan-
taged owing to many of the same factors that made the
Preclose technique unsuitable, such as obesity, scarring,
and severe atherosclerotic disease as mentioned. Con-
versely, the only way we can truly eliminate this would be
through a prospective, randomized study, which may be
ultimately required before the merits of this technique
can be scientifically validated.
The economics of percutaneous access for EVAR and
TEVAR deserve mention. Measuring only the time-based
“usage” cost of the operating room is artificial and not
reflective of all the fiscal complexities that enter into the
in-hospital cost of this expensive therapy. It seemed appro-
priate, however, because operating room time was the only
potential cost end point affected for EVAR, with the obvi-
ous exception of the device cost itself. We purposely did not
consider the cost of the Coons dilators, which being part of
the Preclose technique, should be factored into the overall
device cost. Conversely, this would not have materially
altered the final conclusions of the cost analysis, which
was that the Preclose technique was not necessarily cost-
ontraindications to the Preclose technique. A, Morbid
.ic ceffective.
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regardless of what setting or device. The only justification
from the hospital’s standpoint involves some aggregate
qualitative and quantitative measures of time-savings,
fixed-resource utilization, and patient satisfaction. From a
physician’s standpoint, surgical femoral exposure (Current
Procedural Terminology code 34812) during endovascular
procedures is reimbursed at $373.82 (2006 Medicare Fee
Schedule for Florida, Locality 1) per groin. This means a
loss of nearly $750 per patient for EVAR. Unfortunately,
this discrepancy may have implications in the current set-
ting of declining physician reimbursement.
CONCLUSION
This study represents, to our knowledge, the largest
series of percutaneous endovascular aortic repairs using the
Preclose technique and the first using the Proglide device.
The results indicate that the technique is a safe and effective
method of percutaneous arteriotomy closure after intro-
duction of large sheaths in a select group of patients, with a
higher technical success rate than historically reported with
the Prostar XL device.
The technique is well tolerated by patients, with almost
no postoperative discomfort typical of a groin incision and
rapid return to normal activities. Although to date we have
not had any late ischemic events due to secondary develop-
ment of occlusive disease at the site of Perclose deployment,
long term outcomes of femoral arteries closed with this
technique remains unknown at this time and clinical vigi-
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